Maria Fardis is the founder of AirNexis Therapeutics. AirNexis Therapeutics has raised $200M in total funding. Latest round: Series A.
Maria Fardis is the CEO and co-founder of AirNexis Therapeutics, a clinical-stage biotech company focused on advancing therapeutics for pulmonary diseases. She leads the global clinical development of AN01, a Phase 2 dual PDE3/4 inhibitor for chronic obstructive pulmonary disease (COPD).
Full founder directory · Investor directory · Company funding database · Fundraising library